论文部分内容阅读
目的评价肺血栓栓塞症(PTE)临床路径的效果。方法选取2011~2012年该呼吸内科收治住院的PTE患者60例,分为试验组和对照组,每组30例。对照组按普通流程进行住院管理;实验组按制定的临床路径实施住院管理。记录并比较分析两组的疗效、住院时间、住院总费用、药品费用、住院期间出现并发症的情况以及患者对此次住院的满意度。结果试验组的平均住院时间、平均住院费用与平均药品费用分别为(17.13±2.22)d、(16 545.04±1 557.44)元与(7 050.83±372.74)元,均少于对照组的(19.77±3.41)d、(17 709.45±1 902.05)元与(7 345.75±450.82)元,两组比较差异均有统计学意义(均P<0.05);试验组和对照组的满意度分别为(93.47±3.88)分与(90.90±5.30)分,两组间比较差异有统计学意义(P<0.05)。两组间的治疗效果与并发症发生率比较,差异均无统计学意义(均P>0.05)。结论 PTE临床路径的开展对缩短住院时间、节约住院费用和药品费用以及提高患者满意度均有积极作用,值得临床推广。
Objective To evaluate the clinical effect of pulmonary thromboembolism (PTE). Methods Sixty patients with PTE admitted to the department of respiratory medicine from 2011 to 2012 were divided into experimental group and control group, with 30 cases in each group. Control group according to the normal flow of hospital management; experimental group according to the established clinical pathway implementation hospitalization. Record and compare the curative effect, hospitalization time, total cost of hospitalization, cost of medicine, complications during hospitalization, and patient’s satisfaction with the hospitalization. Results The mean length of hospital stay, average cost of hospitalization and average cost of drugs in the experimental group were (17.13 ± 2.22) d and (16 545.04 ± 1 557.44) yuan and (7 050.83 ± 372.74) yuan, respectively, which were all less than those in the control group (19.77 ± 3.41) d, (17 709.45 ± 1 902.05) yuan and (7 345.75 ± 450.82) yuan respectively. There was significant difference between the two groups (all P <0.05); the satisfaction of the experimental group and the control group were (93.47 ± 3.88) points and (90.90 ± 5.30) points, the difference between the two groups was statistically significant (P <0.05). There was no significant difference between the two groups in the treatment effect and complication rate (all P> 0.05). Conclusion The clinical pathway of PTE has a positive effect on shortening the hospitalization time, saving hospitalization fees and drug costs, and improving patient satisfaction, which is worthy of clinical promotion.